Vericel (VCEL) Shares Outstanding (2010 - 2026)
Vericel (VCEL) reported Shares Outstanding (Entity) of $51.0 million for Q1 2026, up 1.51% on a YoY basis from $50.3 million in Q1 2025, and up 0.77% sequentially from $50.6 million in Q4 2025.
Vericel (VCEL) Shares Outstanding (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 14 years of Shares Outstanding (Entity) data on file, last reported at $51.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 1.51% year-over-year to $51.0 million; the trailing twelve-month figure through Mar 2026 stood at $51.0 million (up 1.51% YoY), and the FY2025 full-year result was $50.6 million, up 2.0% from the prior year.
- Shares Outstanding (Entity) improved to $51.0 million in Q1 2026, from $50.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $51.0 million in Q1 2026 to a low of $47.1 million in Q1 2022.
- A 5-year average of $48.7 million and a median of $48.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) advanced 0.8% in 2022 and rose 3.76% in 2024, its largest moves.
- Tracing VCEL's Shares Outstanding (Entity) over 5 years: stood at $47.3 million in 2022, then gained by 1.22% to $47.8 million in 2023, then increased by 3.76% to $49.6 million in 2024, then rose by 2.0% to $50.6 million in 2025, then climbed by 0.77% to $51.0 million in 2026.
- Business Quant data shows VCEL's Shares Outstanding (Entity) at $51.0 million in Q1 2026, $50.6 million in Q4 2025, and $50.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 50.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.77 Mn |
| Dec 31, 2025 | 50.34 Mn |
| Sep 30, 2025 | 50.49 Mn |
| Jun 30, 2025 | 50.37 Mn |
| Mar 31, 2025 | 49.91 Mn |
| Dec 31, 2024 | 48.85 Mn |
| Sep 30, 2024 | 49.09 Mn |
| Jun 30, 2024 | 48.69 Mn |
| Mar 31, 2024 | 48.14 Mn |
| Dec 31, 2023 | 47.59 Mn |
| Sep 30, 2023 | 47.65 Mn |
| Jun 30, 2023 | 47.57 Mn |
| Mar 31, 2023 | 47.39 Mn |
| Dec 31, 2022 | 47.13 Mn |
| Sep 30, 2022 | 47.18 Mn |
| Jun 30, 2022 | 47.12 Mn |
| Mar 31, 2022 | 46.99 Mn |
| Dec 31, 2021 | 46.47 Mn |
| Sep 30, 2021 | 46.67 Mn |
| Jun 30, 2021 | 46.40 Mn |